Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKazera Global Regulatory News (KZG)

Share Price Information for Kazera Global (KZG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.65
Bid: 0.60
Ask: 0.70
Change: 0.00 (0.00%)
Spread: 0.10 (16.667%)
Open: 0.65
High: 0.65
Low: 0.65
Prev. Close: 0.65
KZG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan Facility - Replacement

28 Oct 2021 07:00

RNS Number : 4943Q
Kazera Global PLC
28 October 2021
 

The following amendment has been made to the ' Loan Facility' announcement released on 27.10.2021 at 10:24 under RNS No 4333Q.

Volumes of Tantalum produced will increase with the aim of exceeding 10,000 kilograms per month by the end of 2022, rather than 10,000 tonnes.

All other details remain unchanged.

The full amended text is shown below.

 

 

27 October 2021

Kazera Global plc

("Kazera" or the "Company")

Loan Facility to Fund Transition Into Cash Generation

Kazera Global plc, the AIM quoted investment company, is pleased to announce new financing arrangements that will see the Company through to cash generation over the next 6 months.

 

Highlights

· New loan facility which will allow the Company to draw down up to £250,000 over the next 6 months

· Sums advanced by Westleigh Investments Holdings Limited to be converted into term loan on the same terms

· Deferred director salaries of more than £125,000 converted into term loans on the same basis but subordinated to the above

· Company anticipates that all its existing operations will be trading profitably prior to the end of 2021.

· It further anticipates being cash flow positive in early 2022.

· Within 6 months of the Mining Permit for the Heavy Mineral Sands operation being granted it expects to substantially boost positive cash flow generation.

· Loan facility being put in place to cover any cash flow shortfalls during the next 6 months.

 

 

The Loan Facilities

New Facility

The Company has entered into a new loan facility of £250,000 ("the New Facility") with RiverFort Global Opportunities PCC Limited and Align Research Limited (Align").

The New Facility allows drawdowns over the next 6 months and is repayable at the end of 2022. Sums drawn down on the New Facility attract a fixed interest rate of 5% payable for the period ended 30 April 2022 and 0.5% per month thereafter until the repayment date of 31 Dec 2022. The lenders may also elect to receive this interest in new ordinary shares in the capital of the Company at a deemed price of 2p per share on the repayment date.

Director Loans

In addition, Westleigh Investments Holdings Limited (a company controlled by Giles Clarke and Nick Harrison) has agreed to formalize the arrangements pursuant to which it has financed the Company's operations over recent months into a fixed term loan of £200,0000 repayable at the end of 2022 (the "Westleigh Loan"). The Westleigh Loan ranks pari passu with the New Facility, save that any drawdowns from the New Facility cannot be used for its repayment.

Giles Clarke and Nick Harrison have also agreed that the deferred salaries owing to them of £127,493 will be converted into a fixed term loan repayable at the end of 2022 (the "Deferred Salaries"). The Deferred Salaries are on identical terms to the New Facility however are subordinated and can only be repaid once the New Facility has been repaid.

(together, the "Director Loans").

Warrant Issuance

In consideration for the lenders entering into the New Facility and the Director Loans the Company has agreed to issue warrants (the "Warrants") over:

 

· 28.75m new ordinary shares in the capital of the Company with an exercise price of 2 pence per new ordinary share; and

· 10.65m new ordinary shares in the capital of the Company with an exercise price of 2.7 pence per new ordinary share.

 

In each case, the Warrants will have an expiry date of 30 October 2023.

 

 

The Warrants will be issued as follows:

 

Entity

Warrants at 2p

Warrants at 2.7p

Westleigh Investments

10,000,000

3,703,702

RiverFort Global Opportunities

7,500,000

2,777,776

Giles Clarke & Nick Harrison

6,250,000

2,314,314

Align Research

5,000,000

1,851,851

 

The Company has also agreed to extend the exercise date of the 45,000,000 warrants exercisable at 0.3 pence per new ordinary share currently held by Align (the "Existing Warrants") from 31 March 2022 to 31 March 2023.

 

Forward Strategy

The Company believes that, by the end of 2021, it will have begun to trade profitably and that early in 2022 it will be cash flow positive.

The grant of the Mining Permit for HMS is also now expected before the end of the calendar year. The Company has recently been asked to provide an environmental rehabilitation guarantee, which is apparently one of the last steps prior to the Permit being granted. With the Permit in hand, the Company, as previously announced, expects within 6 months, to begin generating additional profits of up to $300,000 per month. These numbers will be improved even further by introducing a third party to build and operate a separation plant for which discussions are already underway. Simultaneously, the Company is pursuing an application for a Prospecting Right over an area which is approximately 34 times larger than the current site.

Diamond production will also increase as Heavy Mineral Sands are mined, with an estimated increase in diamond production of an additional 300ct per month and with an enhanced value of approximately $750 per carat anticipated.

In Namibia, the expectation is to export the first commercial delivery of Tantalum before the end of the year. Volumes will then steadily increase with the aim of exceeding 10,000 kilograms per month by the end of 2022.

Simultaneously, the focus will be on establishing further mineral reserves as well as on developing the Company's Lithium opportunities.

 

Dennis Edmonds, Kazera Chief Executive Officer, commented: 

"This New Facility, together with the conversion of the current director advances into a fixed term loan, will provide the Company with a cash buffer to overcome any short-term cash issues which might otherwise have hindered its route to profitability and cash generation. There are a number of hurdles to jump before starting to generate serious cash flow, and we now have the resources to do that.

Generating cash from early next year will mean that we can fund our own future expansion and that we would only look to additional funding if it was on terms that substantially improved the Company's prospects.

Particularly exciting for me is the not the fact that we anticipate soon being cash generative, but that we have such enormous potential within our existing operations to build the Company into a genuine success story."

 

Related Party Transactions

Align is committing £100,000 to the New Facility and will be issued with 6,851,851 Warrants as described above. The Company has also agreed to extend the exercise date of the Existing Warrants. Align is a substantial shareholder in the Company and therefore a related party pursuant to Rule 13 of the AIM Rules for Companies.

Together Westleigh, Giles Clarke and Nicholas Harrison will be committing an aggregate of £327,493 to the Company pursuant to the Director Loans. Westleigh, Giles Clarke and Nicholas Harrison will also be issued with an aggregate of 22,268,016 Warrants as described above. Westleigh is ultimately owned by Giles Clarke and Nick Harrison who are directors of the Company. Accordingly, Westleigh, Giles Clarke and Nicholas Harrison are related parties of the Company pursuant to Rule 13 of the AIM Rules for Companies.

The independent directors of Kazera, having consulted with the Company's Nominated Adviser finnCap, consider that the entry into the New Facility with Align, the Directors Loans with Westleigh, Giles Clarke and Nicholas Harrison, the issuance of Warrants to each of those parties and the extension to the Existing Warrants are fair and reasonable insofar as the Company's shareholders are concerned.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No. 596/2014 ('MAR').

 

For further information on the Company, visit: www.kazeraglobal.com

 

Kazera Global plc (c/o Camarco)

Dennis Edmonds (CEO)

Tel: +44 (0)203 757 4980

 

finnCap (Nominated Adviser and Joint Broker)

Christopher Raggett / Charlie Beeson (corporate finance)

 

Tel: +44 (0)207 220 0500

 

Camarco (PR)

Gordon Poole / James Crothers / Hugo Liddy

 

 

  Tel: +44 (0)20 3781 8331

 

**ENDS**

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFLDIVLDFIL
Date   Source Headline
21st Dec 201712:00 pmRNSNotice of final results - Delay and Suspension
20th Dec 20177:00 amRNSInvestee Company Operational Update
23rd Oct 20177:00 amRNSInvestee Company Operational Update
13th Oct 201710:23 amRNSHolding(s) in Company
4th Oct 20175:09 pmRNSHolding(s) in Company
28th Sep 201712:00 pmRNSHolding(s) in Company
18th Sep 20177:00 amRNSInvestee Company Operational Update
17th Aug 201712:48 pmRNSGrant of Share Options
15th Aug 201712:52 pmRNSResult of General Meeting
27th Jul 20177:00 amRNSPlacing to raise £3.75 million
17th Jul 20177:00 amRNSMultiyear Supply Agreement
30th Jun 201711:52 amRNSInvestee Company Operational Update - Amendment
30th Jun 20177:00 amRNSInvestee Company Operational Update
4th May 20177:00 amRNSChange of Adviser
30th Mar 201710:48 amRNSSix Month Interim Results ended 31 December 2016
27th Mar 20177:00 amRNSInvestee Company Operational Update
15th Mar 20177:00 amRNSDirectorate Change
13th Mar 20179:01 amRNSTR-1: Notification of Major Interest in Shares
9th Feb 20179:40 amRNSTR-1: Notification of Major Interest in Shares
1st Feb 20179:58 amRNSPlacing to raise £1.25 million
1st Feb 20177:00 amRNSPlacing to raise £1.25 million
30th Jan 20174:40 pmRNSSecond Price Monitoring Extn
30th Jan 20174:35 pmRNSPrice Monitoring Extension
30th Jan 20179:05 amRNSSecond Price Monitoring Extn
30th Jan 20179:00 amRNSPrice Monitoring Extension
26th Jan 20179:53 amRNSTR-1: Notification of Major Interest in Shares
25th Jan 20177:00 amRNSInvestee Company Operational Update
16th Jan 20174:27 pmRNSResults of Annual General Meeting
9th Jan 20177:00 amRNSAppointment of new Chief Executive Officer
20th Dec 20164:32 pmRNSNotice of AGM
19th Dec 20167:00 amRNSPreliminary Results for Year Ended 30 June 2016
30th Nov 201612:19 pmRNSCompany Presentation
29th Nov 20167:00 amRNSInvestee Company Operational Update
22nd Nov 20167:00 amRNSInvestor Evening - 1 December 2016
3rd Oct 20167:00 amRNSInvestee Company Operational Update
16th Sep 20167:00 amRNSInvestee Company Operational Update
10th Aug 20163:18 pmRNSHolding(s) in Company
4th Aug 201612:29 pmRNSResult of General Meeting
2nd Aug 20162:56 pmRNSHolding(s) in Company
20th Jul 20167:00 amRNSPlacing to raise £2.0 million
27th Apr 20167:00 amRNSRelated Party Transaction
4th Apr 201611:10 amRNSDirectors' Exercise of Options
1st Apr 20167:00 amRNSChange of Nominated Adviser
31st Mar 20167:00 amRNSInterim Results and First Consignment Leaves Mine
3rd Feb 20167:00 amRNSOperational Update
18th Dec 201511:18 amRNSResult of AGM
23rd Nov 20157:00 amRNSPreliminary results for the year ended 30 June 15
13th Nov 20153:24 pmRNSHolding(s) in Company
13th Nov 20153:14 pmRNSPress speculation
3rd Nov 20157:00 amRNSSuccessful Commissioning of Process Plant

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.